Jacobs Levy Equity Management, Inc Oyster Point Pharma, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $73,933 - $230,014	-20,537 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.58 - $17.65 $176,207 - $362,478	20,537 New	20,537 $239,000
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $317,344 - $591,627	-31,204 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $364,150 - $563,856	31,204 New	31,204 $370,000
Q2 2021 Aug 16, 2021	SELL	$16.25 - $21.51 $322,237 - $426,543	-19,830 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.92 - $25.86 $355,353 - $512,803	19,830 New	19,830 $362,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.